A medical technology company founded in 1965, Terumo BCT is headquartered in the state of Colorado in the U.S. It is committed to providing comprehensive solutions in the fields of blood component ...

The abstracts identify long-term clinical and economic benefits of aRBCX on Terumo BCT’s Spectra Optia ™ Apheresis System versus manual RBCX procedures, in adults and children respectively.

The COVID-19 pandemic had a positive impact on the global apheresis market due to the vast application of plasma therapy in the remedy of COVID-19 infected patients. Furthermore, the US FDA granted ...